Forte Biosciences Inc. (NASDAQ: FBRX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT FORTE BIOSCIENCES INC.

Forte Biosciences Inc. (NASDAQ: FBRX)
Listen to this Section


$19.01
+0.3000 ( +1.60% ) 77.6K

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).

Clinical Trial Pipeline Stages


Drug Name Stage
FB102DetailsGraft-versus-host disease Phase 1

Market Data


Open $19.01
Previous Close $18.71
Volume 77.6K
Market Cap $379.68M
Day Range $16.84 - $22.47
52 Week Range $9.10 - $35.80
Shares Outstanding 20.48M
Change % +1.60%
Net Change ▲ 0.3000
Insider Ownership -0.03%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,867,963.00

Date Type Amount Purchased Purchaser
2024-01-03 Sale -31250.00 Wagner Paul A.
2023-12-20 Buy 10000.00 Wagner Paul A.
2023-12-15 Buy 10520.00 Wagner Paul A.
2023-12-12 Buy 25000.00 Wagner Paul A.
2023-12-08 Buy 36203.00 Wagner Paul A.
2023-11-22 Buy 5300.00 Wagner Paul A.
2023-10-03 Sale -31250.00 Wagner Paul A.
2023-10-03 Sale -7500.00 Chen Hubert C
2023-10-03 Sale -9375.00 Riley Antony A
2023-09-20 Sale -25000.00 Brun Scott C.

SEC Filings


Form Type Description Pages Date
schedule Other 1 Nov 14, 2025
schedule Other 2 Nov 14, 2025
10-q Quarterly Reports 61 Nov 14, 2025
8-k 8K-related 14 Nov 14, 2025
schedule Other 5 Oct 07, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Oct 02, 2025
8-k 8K-related 83 Aug 14, 2025
10-q Quarterly Reports 64 Aug 14, 2025
4 Insider transactions 1 Jul 03, 2025

Latest News